Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

This Vital Farms Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Author: Avi Kapoor | January 27, 2025 09:27am

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Telsey Advisory Group analyst Sarang Vora initiated coverage on Vital Farms, Inc. (NASDAQ:VITL) with an Outperform rating and announced a price target of $52. Vital Farms shares closed at $43.14 on Friday. See how other analysts view this stock.
  • D. Boral Capital analyst Jason Kolbert initiated coverage on Scilex Holding Company (NASDAQ:SCLX) with a Buy rating and announces Price Target of $22. Scilex Holding shares closed at $0.4404 on Friday. See how other analysts view this stock.
  • Alliance Global Partners initiated coverage on Palladyne AI Corp. (NASDAQ:PDYN) with a Buy rating and announced a price target of $15. Palladyne AI shares closed at $9.86 on Friday. See how other analysts view this stock.
  • Jones Trading analyst Debanjana Chatterjee initiated coverage on Sagimet Biosciences Inc. (NASDAQ:SGMT) with a Buy rating and announced a price target of $42. Sagimet Biosciences shares closed at $4.20 on Friday. See how other analysts view this stock.
  • Jones Trading analyst Soumit Roy initiated coverage on Mural Oncology plc (NASDAQ:MURA) with a Buy rating and announced a price target of $16. Mural Oncology shares closed at $3.95 on Friday. See how other analysts view this stock.

Considering buying VITL stock? Here’s what analysts think:

Read This Next:

Posted In: MURA PDYN SCLX SGMT VITL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist